Compliance Question of the Week – General

What codes do we report for monoclonal antibody Beyfortus™?

What factors should be documented when determining whether an antineoplastic agent is being administered for cancer or another cause?

From a claims perspective, what are some red flags when reviewing infusion and injection claims?

Why can’t we code 95180 (rapid desensitization) and chemotherapy drug administration codes together when we perform carboplatin desensitization?

What is the difference between white bagging and brown bagging regarding patient-supplied drugs?

We have a patient who received three hours of IV hydration. During that time, the patient received two different drugs by intravenous push. Can the entire 3 hours of IV hydration be coded with the intravenous push injections?

Can an IVP be coded when a stop time has not been recorded for the infusion?

If a patient has rheumatoid arthritis and comes in for a methotrexate injection, do we use the chemotherapy injection code?

Can you charge an XS modifier with IVP drug administration codes?

If a patient has rheumatoid arthritis and comes in for a methotrexate injection, do we use the chemotherapy injection code?

What time can be used for infusion stop if patient is in the clinic and has a negative reaction requiring inpatient admission?

Can a subcutaneous injection of insulin administered to a patient be billed?